0001683168-22-008721.txt : 20221230 0001683168-22-008721.hdr.sgml : 20221230 20221230170219 ACCESSION NUMBER: 0001683168-22-008721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221229 FILED AS OF DATE: 20221230 DATE AS OF CHANGE: 20221230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weigerstorfer Philippe CENTRAL INDEX KEY: 0001751449 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33216 FILM NUMBER: 221502523 MAIL ADDRESS: STREET 1: 1129 N. MCDOWELL BLVD. CITY: PETALUMA STATE: CA ZIP: 94954 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001367083 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680423298 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 5445 CONESTOGA COURT, SUITE 150 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 800-759-9305 MAIL ADDRESS: STREET 1: 5445 CONESTOGA COURT, SUITE 150 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc. DATE OF NAME CHANGE: 20060622 4 1 ownership.xml X0306 4 2022-12-29 0 0001367083 Sonoma Pharmaceuticals, Inc. SNOA 0001751449 Weigerstorfer Philippe C/O SONOMA PHARMACEUTICALS, INC. 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 1 0 0 0 Stock option (right to buy) 1.08 2022-12-29 4 A 0 20000 A 2032-12-29 Common Stock 20000 50000 D The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control. The options were awarded and granted to Mr. Weigerstorfer for services performed on the Board of Directors as part of the Company's annual grant of stock options. /s/ Amy Trombly as attorney-in-fact 2022-12-30